Cerebral venous sinus thrombosis following intracerebral hemorrhage after <scp>COVID</scp> ‐19 <scp>AstraZeneca</scp> vaccination: A case report
Arsh Haj Mohamad Ebrahim Ketabforoush, Ghazale Molaverdi, Matineh Nirouei, Nahid Abbasi Khoshsirat
Abstract
The patient was a 55-year-old female patient who presented with sudden onset of left hemiplegia, facial hemiparesis, and hypoesthesia. She has received her first dose of the AstraZeneca COVID-19 vaccine. This case indicates that vaccination may raise the hypercoagulable state even in a condition of post-ICH and anticoagulant prophylaxis.
Topics & Concepts
MedicineIntracerebral hemorrhageVenous thrombosisCoronavirus disease 2019 (COVID-19)Intracranial ThrombosisVaccinationThrombosisAnesthesiaInternal medicineVirologySubarachnoid hemorrhageDiseaseInfectious disease (medical specialty)Cerebral Venous Sinus ThrombosisHeparin-Induced Thrombocytopenia and ThrombosisVenous Thromboembolism Diagnosis and Management